Clinical Trial Results

A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies

Milk Thistle Clinical Trial in Pediatric NAFLD

Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours

Spartan Stem, World Cup and World Liner Post Market Clinical Follow-up Study

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

Zopa Retreatment and Vector Shedding in Adults With RRP

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

Knee Related Subchondral Bone Lesions Treated With IOBP